Literature DB >> 22644185

Migraine and depression comorbidity: antidepressant options.

R Torta1, V Ieraci.   

Abstract

Migraine and mood depression demonstrate a high clinical relation and share, also with pain, neurobiological mechanisms, particularly neuro-transmettitorial and phlogistic ones. The choice of an antidepressant to treat both depression and migraine is determined by its efficacy, safety, and tolerability. Antidepressants share comparable effectiveness for the treatment of depressive disorders, but their efficacy on headache varies widely: Tricyclic antidepressants are more effective than SNRIs and SSRIs, but demonstrate dose-limiting side effects.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22644185     DOI: 10.1007/s10072-012-1055-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  4 in total

Review 1.  [Integrated headache care network. Kiel Migraine and Headache Center and German National Headache Treatment Network].

Authors:  H Göbel; K Heinze-Kuhn; I Petersen; A Göbel; A Heinze
Journal:  Schmerz       Date:  2013-04       Impact factor: 1.107

2.  The Impacts of Migraine among Outpatients with Major Depressive Disorder at a Two-Year Follow-Up.

Authors:  Ching-I Hung; Chia-Yih Liu; Ching-Hui Yang; Shuu-Jiun Wang
Journal:  PLoS One       Date:  2015-05-22       Impact factor: 3.240

3.  Migraine patients visiting Chinese medicine hospital: Protocol for a prospective, registry-based, real-world observational cohort study.

Authors:  Shaohua Lyu; Claire Shuiqing Zhang; Anthony Lin Zhang; Jingbo Sun; Charlie Changli Xue; Xinfeng Guo
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.240

Review 4.  Chronic migraine: A process of dysmodulation and sensitization.

Authors:  Min Su; Shengyuan Yu
Journal:  Mol Pain       Date:  2018-04-12       Impact factor: 3.395

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.